Classes: Difference between revisions
From Pharmacopedia
More actions
| [checked revision] | [checked revision] |
MDElliottMD (talk | contribs) Add Beta Blockers subsection under Anxiolytics & Sedative-Hypnotics |
Terminology sweep (site-wide): drug/medication → medicine |
||
| Line 21: | Line 21: | ||
=== Monoamine Oxidase Inhibitors (MAOIs) === | === Monoamine Oxidase Inhibitors (MAOIs) === | ||
Inhibit MAO-A and/or MAO-B, increasing monoamine levels. Require strict dietary and | Inhibit MAO-A and/or MAO-B, increasing monoamine levels. Require strict dietary and medicine interaction precautions. Subclasses: | ||
* '''Irreversible non-selective MAOIs''' — inhibit both MAO-A and MAO-B permanently | * '''Irreversible non-selective MAOIs''' — inhibit both MAO-A and MAO-B permanently | ||
* '''Reversible MAO-A inhibitors (RIMAs)''' — safer interaction profile; displaceable by tyramine | * '''Reversible MAO-A inhibitors (RIMAs)''' — safer interaction profile; displaceable by tyramine | ||
| Line 300: | Line 300: | ||
== Research Materials == | == Research Materials == | ||
Compounds primarily of research interest, with limited or no human clinical approval. Many are analogues of approved medicines or classical psychoactive substances. Use of the term '''material''' is preferred over " | Compounds primarily of research interest, with limited or no human clinical approval. Many are analogues of approved medicines or classical psychoactive substances. Use of the term '''material''' is preferred over "medicine" or "substance" in this context. | ||
=== Lysergamides === | === Lysergamides === | ||